Tech

The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs


Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to …

Read more at www.benzinga.com

Show More
Back to top button